Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s Why

Terumo Corp. (OTCMKTS:TRUMY)’s share price gapped down before the market opened on Friday . The stock had previously closed at $12.76, but opened at $12.1501. Terumo shares last traded at $12.54, with a volume of 652 shares.

Terumo Stock Down 0.8%

The firm’s 50-day moving average price is $13.96 and its 200 day moving average price is $15.75. The company has a current ratio of 2.51, a quick ratio of 1.46 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $18.67 billion, a price-to-earnings ratio of 21.83 and a beta of 0.74.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings results on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). Terumo had a return on equity of 9.13% and a net margin of 11.74%.The firm had revenue of $1.94 billion for the quarter, compared to analyst estimates of $1.82 billion.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.